# Takarazuka City Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/takarazuka-city-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 58 |
| Citations | 34,257 |
| City | Takarazuka |
| Country | JP |
| Description | Takarazuka City Hospital is a research organisation in Takarazuka, JP. OpenAlex records 1,620 works and 34,257 citations for it. 372 researchers list it as their most recent affiliation. |
| Homepage | http://www.city-hospital.takarazuka.hyogo.jp/about/index.html |
| OpenAlex ID | https://openalex.org/I4210153815 |
| Researchers | 372 |
| ROR ID | https://ror.org/04w3f9b42 |
| Type | healthcare |
| Works | 1,620 |

## University papers

- [Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia](https://scholariq.org/papers/disease-specific-analyses-of-unrelated-cord-blood-transplantation-compared-with/)
- [A Genetic Variant in the IL-17 Promoter Is Functionally Associated with Acute Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation](https://scholariq.org/papers/a-genetic-variant-in-the-il-17-promoter-is-functionally-associated-with-acute/)
- [Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor](https://scholariq.org/papers/efficacy-of-osimertinib-plus-bevacizumab-vs-osimertinib-in-patients-with-i-egfr/)
- [Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L](https://scholariq.org/papers/randomized-phase-iii-study-comparing-gefitinib-with-erlotinib-in-patients-with/)

## University top topics

Showing 8 of 25.

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.